GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exact Sciences Corp (NAS:EXAS) » Definitions » Shiller PE Ratio

Exact Sciences (Exact Sciences) Shiller PE Ratio : (As of May. 26, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Exact Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Exact Sciences Shiller PE Ratio Historical Data

The historical data trend for Exact Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Sciences Shiller PE Ratio Chart

Exact Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Exact Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Exact Sciences's Shiller PE Ratio

For the Diagnostics & Research subindustry, Exact Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exact Sciences's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Exact Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Exact Sciences's Shiller PE Ratio falls into.



Exact Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Exact Sciences's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Exact Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.6/131.7762*131.7762
=-0.600

Current CPI (Mar. 2024) = 131.7762.

Exact Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.240 100.560 -0.315
201409 -0.390 100.428 -0.512
201412 -0.380 99.070 -0.505
201503 -0.400 99.621 -0.529
201506 -0.440 100.684 -0.576
201509 -0.450 100.392 -0.591
201512 -0.410 99.792 -0.541
201603 -0.490 100.470 -0.643
201606 -0.460 101.688 -0.596
201609 -0.360 101.861 -0.466
201612 -0.340 101.863 -0.440
201703 -0.320 102.862 -0.410
201706 -0.270 103.349 -0.344
201709 -0.230 104.136 -0.291
201712 -0.180 104.011 -0.228
201803 -0.330 105.290 -0.413
201806 -0.300 106.317 -0.372
201809 -0.370 106.507 -0.458
201812 -0.440 105.998 -0.547
201903 -0.660 107.251 -0.811
201906 -0.300 108.070 -0.366
201909 -0.310 108.329 -0.377
201912 0.540 108.420 0.656
202003 -0.910 108.902 -1.101
202006 -0.450 108.767 -0.545
202009 -1.350 109.815 -1.620
202012 -2.790 109.897 -3.345
202103 -0.180 111.754 -0.212
202106 -1.030 114.631 -1.184
202109 -0.970 115.734 -1.104
202112 -1.280 117.630 -1.434
202203 -1.040 121.301 -1.130
202206 -0.940 125.017 -0.991
202209 -0.840 125.227 -0.884
202212 -0.720 125.222 -0.758
202303 -0.420 127.348 -0.435
202306 -0.450 128.729 -0.461
202309 0.004 129.860 0.004
202312 -0.270 129.419 -0.275
202403 -0.600 131.776 -0.600

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Exact Sciences  (NAS:EXAS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Exact Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Exact Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Exact Sciences (Exact Sciences) Business Description

Traded in Other Exchanges
Address
5505 Endeavor Lane, Madison, WI, USA, 53719
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Executives
Brian Baranick officer: Gen. Mgr., Precision Oncology 441 CHARMANY DRIVE, MADISON WI 53719
Sarah Condella officer: SVP, Human Resources 441 CHARMANY DRIVE, MADISON WI 53719
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Everett Cunningham officer: Chief Commercial Officer C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Jeffrey Thomas Elliott officer: Chief Financial Officer 5505 ENDEAVOR LANE, MADISON WI 53719
James Edward Doyle director 5505 ENDEAVOR LANE, MADISON WI 53719
James Herriott officer: General Counsel 5505 ENDEAVOR LANE, MADISON WI 53719
Katherine S Zanotti director 431 E 9TH STREET, HINSDALE IL 60521
Jacob A Orville officer: General Manager, New Ventures 5505 ENDEAVOR LANE, MADISON WI 53719
Kevin T Conroy director, officer: Vice President 5505 ENDEAVOR LANE, MADISON WI 53719
D Scott Coward officer: SVP and General Counsel 441 CHARMANY DRIVE, MADISON WI 53719
Paul J Clancy director C/O BIOGEN IDEC INC., 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Graham Peter Lidgard officer: SVP, Chief Scientific Officer 5505 ENDEAVOR LANE, MADISON WI 53719
Michael S Wyzga director RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, CAMBRIDGE MA 02139
Torsten Hoof officer: General Manager, International 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063